Spyre Therapeutics
SYRE
SYRE
87 hedge funds and large institutions have $352M invested in Spyre Therapeutics in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+17
Holders Change %
+24.29%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
25
Increased
43
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$25M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$24.7M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.2M |
| 4 |
BlackRock
New York
|
+$12.1M |
| 5 |
O
OrbiMed
New York
|
+$10.6M |
